Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Jan 2024 for Equillium, Inc., €7,790. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joel Rothman: trading record in brief
All filings by Joel Rothman on record concern Equillium, Inc., in the capacity of senior executive. Between 10 June 2021 and 9 June 2023, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 3 January 2024, reports a share grant of €7,790 in Equillium, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joel Rothman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
15,000 shares@ US$0.5614.4% of flowCommon StockSEC:0001209191-24-000518:0
6,244 shares@ US$1.8520.2% of flowCommon StockSEC:0001209191-23-001366:0
1,290 shares@ US$2.357.4% of flowCommon StockSEC:0001209191-21-069176:0
7,742 shares@ US$2.3541.2% of flowCommon stock, par value $0.0001 per shareSEC:0001209191-21-040313:0
4 of 4 declarations
